IM Cannabis' Q4 Revenue: Gross Profit Drops Due To Negative Impact Of Israel-Hamas War, Sees Germany As Growth Opportunity

By Jelena Martinovic

IM Cannabis Corp . (NASDAQ: IMCC ) (CSE: IMCC ) announced its financial and operational results on Thursday for the year ended Dec. 2023.

The Toronto-headquartered medical cannabis company with a focus on Israel and Germany reported a 10% year-over-year decrease in

You are viewing a robot-friendly page.Click hereto reload in standard format.